Skip to main content

Table 2 Comparison of clinical characteristics between survivors and non-survivors of cholinesterase inhibitor poisoning (N = 6832)

From: One-year mortality among hospital survivors of cholinesterase inhibitor poisoning based on Taiwan National Health Insurance Research Database from 2003 to 2012

  Non-survivors (N = 900) Survivors (N = 5932) 95% CI of difference between means or percentages P value
Age, mean ± SD, years old 62.18 ± 15.48 54.36 ± 16.34 6.682 to 8.959 < 0.0001
Female Sex, N (%) 306 (34.0) 1732 (29.2) 1.49 to 8.2% 0.0033
Comorbidities
 Diabetes mellitus, N (%) 117(13.0) 656 (11.1) −0.38 to 4.4% 0.0867
 Hypertension, N (%) 78 (8.7) 831 (14.0) 3.09 to 7.28% < 0.0001
 Coronary artery disease, N (%) 17 (1.9) 175 (3.0) −0.097 to 2.02% 0.0727
 Cerebrovascular accident, N (%) 32 (3.6) 145 (2.4) 0.0045 to 2.68% 0.0506
 Chronic renal failure, N (%) 20 (2.2) 33 (0.6) 0.71 to 2.8% < 0.0001
 Chronic obstructive pulmonary disease, N (%) 16 (1.8) 95 (1.6) −0.64 to 1.34% 0.6967
 Asthma, N (%) 3 (0.3) 42 (0.7) −0.25 to 0.75% 0.195
 Liver failure, N (%) 11 (1.2) 19 (0.3) 0.27 to 1.86% < 0.0001
Atropine use, N (%) 698 (77.6) 2955 (49.8) 0.55 to 4.69% < 0.0001
Pralidoxime use, N (%) 564 (62.7) 2915 (49.1) 10.1 to 17.02% < 0.0001
Hemodialysis, N (%) 59 (6.6) 65 (1.1) 3.94 to 7.34% < 0.0001
Mechanical ventilation, N (%) 671 (74.6) 1339 (22.6) 48.83 to 55.01% < 0.0001
Pneumonia, N (%) 85 (9.4) 407 (6.9) 0.55 to 4.69% 0.0052
Hospital days, mean ± SD 6.58 ± 12.31 9.61 ± 11.43 −3.846 to −2.225 < 0.0001
  1. CI, Confidence interval; Data are presented as mean ± SD or N (%)